##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 75 Download : 43

##plugins.themes.academic_pro.article.main##

Abstract

Gallstones may be biochemically categorized into three types: cholesterol stones, brown pigment stones, and black pigment stones. There are two potential anatomical locations for gall stones: choledocholithiasis (in the common bile duct) and cholelithiasis (in the gall bladder). Gallstones can be symptomatic (showing symptoms) or asymptomatic (not showing symptoms). Low bile salt levels, impaired gall bladder motility, a high-cholesterol diet, and other similar factors are the main causes of gallstones. Factors that increase the likelihood of gall stones developing include being overweight, being female, having a history of the condition in the family, losing weight quickly, and not getting enough vitamin B12 or folic acid. Acute cholecystitis and feverish sickness characterized by right upper quadrant discomfort and tenderness (Murphy sign) are among the clinical manifestations

Keywords

family asymptomatic categorized female

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Dr. Hazim Mohammed-youns Hussein. (2024). Surgical Management of Cholelithiasis Cross-sectional study of 41 patients. Texas Journal of Medical Science, 31, 41–51. Retrieved from https://zienjournals.com/index.php/tjms/article/view/5236

References

  1. . Johnston DE, Kaplan MM. Pathogenesis and Treatment of Gallstones. N Engl J Med. 1993;328(6):412-21.
  2. Haribhakti SP, Mistry JH. Techniques of laparoscopic cholecystectomy: Nomenclature and selection. J Minim Access Surg. 2015;11(2):113 – 8.
  3. AllenSN.Gallbladderdisease:pathophysiology,diagnosis,andtreatment.USPharm.201 3;38(3):33-41.
  4. Hung S-C, Liao K-F, Lai S-W, Li C-I, Chen W-C. Risk factors associated
  5. withsymptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol.2011;11(1):111.
  6. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172.
  7. Elmehdawi RR, Elmajberi SJ, Behieh A, Elramli A. Prevalence of gall bladder stones among type 2 diabetic patients in Benghazi Libya: a case-control study. Libyan J Med. 2008;4(1):27-30.
  8. Sodhi JS, Zargar SA, Khateeb S, et al. Prevalence of gallstone disease in patients with type 2 diabetes and the risk factors in North Indian population: A case control study. Indian J Gastroenterol. 2014;33(6):507-511.
  9. Lv J, Yu C, Guo Y, et al. Gallstone Disease and the Risk of Type 2 Diabetes. Sci Rep. 2017;7(1):15853. doi:10.1038/s41598-017-14801-
  10. A Study on Clinical Presentation and Management of Gall StoneDisease Presenting In a Tertiary Care Hospital Dr. Abhilash Mohanty, Dr. Indrajeet Kumar Rajan.
  11. Gallstone disease, Sponsoring Organisation: Association of Upper gastrointestinal Surgeons, Date of first publication: September 2013 Date of revised evidence search: February 2016 Date of revised publication: December 2016
  12. Prevalence and Risk Factors for Gallstones among Population in Riyadh City, KSA 2017 Youssef Ahmed Alishi1, Faris Ahmad Howaish1, Fahad Abdulrahman Alhamdan1, Ahmed Abdullah Almalki2, Salman Assal Alqahtani3, Saif Abdullah Alharthi4, Ahmed Saleh Alanazi5, Abdullah Hadi Saaty Alsuroji6
  13. Gall stones: a fundamental clinical review
  14. Muhammad Nouman Iqbal1, Muhammad Arslan Iqbal1, Rukhsar Javaid2, Muhammad Waseem Abbas2
  15. Fitzgerald JEF, Fitzgerald LA, Maxwell-Armstrong CA, Brooks AJ. Recurrent gallstone ileus: time to change our surgery?. J Dig Dis. 2009;10(2):149-51.
  16. Kaechele V, Wabitsch M, Thiere D, Kessler AL, Haenle MM, Mayer H, et al. Prevalence of gallbladder stone disease in obese children and adolescents: Influence of the degree of obesity sex and pubertal development. J Pediatr Gstroenterol Nutr. 2006;42(1):66-77.
  17. Wesdrop I, Bosman D, de Graaff A, Aronson D, vanderBlif FM, Taminiau J. Clinical presentations and predisposing factors of cholelithiasis and sludge in children. J Pediatr Gastroenterol Nutr. 2000;31(4):411-7.
  18. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). The Epidemiology of gallstone disease in Rome, Italy. Prevalence data in men. Hepatology. 1988;8(4):904-6.
  19. Singh V, Trikha B, Nain CK, Singh K, Bose SM. Epidemiology of gallstone disease in Chandigarh: A community-based study. J Gastroenterol Hepatol. 2001;16(5):560-3.
  20. Van Erpecum KJ. Biliary lipids, water and cholesterol gallstones. Biol Cell. 2005;97(11):815-22.
  21. Venneman NG, van Erpecum KJ. Pathogenesis of gallstones Gastroenterol Clin North Am. 2010;39(2):171-83.
  22. Gallstones, Gabriel E Njeze, Department of Surgery, Enugu State University of Technology Teaching Hospital, Park Lane, Enugu, Nigeria
  23. Channa NA, Khand FD, Khand TU, Leghari MH, Memon AN. Analysis of human gallstone by fourier transform infrared (FTIR). Pak J Med Sci 2007;23:546‑50.
  24. Bouchier TA. Gallstones. Proc R Soc Med 1977;70:597‑9.
  25. Berci G. Historical overview of surgical treatment of biliary stone disease. In: MacFadyen BV, Arregui M, Eubanks S, Olsen DO, Peters JH, Soper NJ, et al., editors. Laparoscopic Surgery of the Abdomen. New York: Springer; 2004. p. 139‑42.
  26. Surgical Management of Cholelithiasis ,Mahdi Hussain Al-Saad1, Ali Hussain Alawadh1, Ali Hussain Al-Bagshi1, Mohammed Hussain Al Ali1, Ahmed Abdullah Alshehab1, Abdulraheem Abdulelah Alhodar1, Mustafa Hussain Alshawaf1, Ahmad Metaib Aldhafeeri1
  27. Management of Gallstones,Cha rles F. Bellows , M.D., and David H. Berge r, M.D., Baylor College of Medicine, Houston, Texas,Richa rd A. Crass , M.D., University of Florida Health Science Center, Jacksonville, Florida